South Wales, Sept. 18 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "FOVENTA" on Sept. 3. The details about the trademark application no. UK00004440258 published in the journal no. 2026/038 (Sept. 18).
With Haseltine Lake Kempner LLP as representative, Foventa Therapeutics Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations; medicinal preparations; medicines for human purposes; pharmaceutical substances; Pharmaceutical and medicinal preparations and substances; ophthalmic preparations and eye drops; topical ophthalmic formulations; ocular pharmaceuticals; pharmaceuticals comprising small molecule compounds and inhibitors; pharmaceutical formulations for trans-scleral delivery to the retina; pharmaceutical preparations for the treatment and prevention of ocular diseases and disorders; pharmaceutical preparations for the treatment and prevention of retinal diseases; pharmaceutical preparations for the treatment and prevention of retinal vascular diseases; pharmaceutical preparations for the treatment and prevention of macular degeneration; pharmaceutical preparations for the treatment and prevention of diabetic eye disease, and diabetic retinopathy; pharmaceutical preparations for the treatment and prevention of non-proliferative diabetic retinopathy (NPDR); clinical medical reagents.
Class 42 : Scientific and technological services and research and design relating thereto; medical research; pharmaceutical research and development; biotechnology research and development; research and development in the areas of pharmaceuticals, biotechnology, ophthalmology, retinal diseases, macular degeneration, drug discovery and small molecule therapeutics; development of pharmaceutical preparations and medicines; drug discovery and development services; drug formulation research and development; laboratory research services relating to pharmaceuticals and biopharmaceuticals; drug trialling and clinical research; conducting clinical trials for pharmaceuticals; conducting pre-clinical and clinical trials for ophthalmic therapeutics; advisory, consultancy and information services relating to all the aforesaid.
Class 44 : Medical services; medical testing; medical examination; provision of medical information; medical advisory and consultancy services; providing medical information in the fields of ophthalmology, retinal diseases, and macular degeneration; medical consultations; medical care; advisory and consultancy services relating to eye care, retinal disease management, and diabetic eye disease.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004440258
Disclaimer: Curated by HT Syndication.
